🇺🇸 FDA
Patent

US 7030080

Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof

expired A61KA61K38/00

Quick answer

US patent 7030080 (Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof) held by The Regents of the University of California expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00